News | November 03, 2021
Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)